Literature DB >> 15550850

Overexpression of Her2/neu, estrogen and progesterone receptors in invasive micropapillary carcinoma of the breast.

Hajime Kuroda1, Goi Sakamoto, Kiyoshi Ohnisi, Shinji Itoyama.   

Abstract

BACKGROUND: Invasive micropapillary carcinoma (IMC) of the breast is a rare subtype of breast carcinoma that has an extremely high incidence of lymph node metastasis and poor clinical outcome. Furthermore, there has been interest in the prognostic markers related to the biological characteristics of breast carcinoma, such as the status of Her2/neu, estrogen receptor (ER) and progesterone receptor (PgR).
MATERIALS AND METHODS: We reviewed 671 cases of primary breast carcinoma which were surgically resected between 1990 and 2003. Of these, 27 cases of invasive ductal carcinoma of the breast with a pure or partial micropapillary component were reported. Tests for Her2/neu protein, estrogen receptor (ER) and progesterone receptor (PgR) were performed on paraffin sections. The relationship among these markers was analyzed and statistical significance determined by chi-square test.
CONCLUSION: The rate of Her2/neu protein overexpression, ER and PgR status was quite similar to those of common breast carcinomas.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15550850     DOI: 10.1007/bf02984553

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  4 in total

1.  HER2 immunohistochemical and fluorescence in situ hybridization discordances in invasive breast carcinoma with micropapillary features.

Authors:  Rachel L Stewart; Justin E Caron; Evin H Gulbahce; Rachel E Factor; Katherine B Geiersbach; Erinn Downs-Kelly
Journal:  Mod Pathol       Date:  2017-07-28       Impact factor: 7.842

2.  Clinicopathologic study of invasive micropapillary carcinoma of the breast.

Authors:  Shen-Li Tang; Ji-Qiao Yang; Zheng-Gui Du; Qiu-Wen Tan; Yu-Ting Zhou; Di Zhang; Qing Lv
Journal:  Oncotarget       Date:  2017-06-27

Review 3.  Micropapillary Breast Carcinoma: From Molecular Pathogenesis to Prognosis.

Authors:  Georgios-Ioannis Verras; Levan Tchabashvili; Francesk Mulita; Ioanna Maria Grypari; Sofia Sourouni; Evangelia Panagodimou; Maria-Ioanna Argentou
Journal:  Breast Cancer (Dove Med Press)       Date:  2022-03-12

4.  HER2 Immunohistochemistry in Invasive Micropapillary Breast Carcinoma: Complete Assessment of an Incomplete Pattern.

Authors:  Marjorie Perron; Hannah Y Wen; Matthew G Hanna; Edi Brogi; Dara S Ross
Journal:  Arch Pathol Lab Med       Date:  2021-08-01       Impact factor: 5.686

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.